Stage IVA Cervical Cancer Completed Phase 2 Trials for Pegfilgrastim (DB00019)

IndicationStatusPhase
DBCOND0028785 (Stage IVA Cervical Cancer)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01266447Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical CancerTreatment